EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   2.7.4.21 | Alzheimer Disease |
27345265 |
Contribution of polymorphic variation of inositol hexakisphosphate kinase 3 (IP6K3) gene promoter to the susceptibility to late onset Alzheimer's disease. |
diagnostic usage
ongoing research
unassigned |
2
2
0 |
| 2.7.4.21 | Amyotrophic Lateral Sclerosis |
28413866 |
Inositol Hexakisphosphate Kinase 2 is a Presymptomatic Biomarker for Amyotrophic Lateral Sclerosis. |
ongoing research
therapeutic application
unassigned |
2
1
0 |
| 2.7.4.21 | Amyotrophic Lateral Sclerosis |
32929655 |
Inositol hexakisphosphate kinase 2 promotes cell death of anterior horn cells in the spinal cord of patients with amyotrophic lateral sclerosis. |
ongoing research
unassigned |
4
0 |
| 2.7.4.21 | Autoimmune Diseases |
22446964 |
Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles. |
causal interaction
unassigned |
4
0 |
| 2.7.4.21 | Breast Neoplasms |
33767863 |
IP6K2 predicts favorable clinical outcome of primary breast cancer. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
3
4
2
0 |
| 2.7.4.21 | Breast Neoplasms |
34229060 |
miR-125a-5p impairs the metastatic potential in breast cancer via IP6K1 targeting. |
causal interaction
therapeutic application
unassigned |
2
3
0 |
| 2.7.4.21 | Carcinogenesis |
27140681 |
Deletion of inositol hexakisphosphate kinase 1 (IP6K1) reduces cell migration and invasion, conferring protection from aerodigestive tract carcinoma in mice. |
causal interaction
ongoing research
therapeutic application
unassigned |
4
4
4
0 |
| 2.7.4.21 | Carcinogenesis |
32992691 |
The Key Role of IP6K: A Novel Target for Anticancer Treatments? |
causal interaction
diagnostic usage
therapeutic application
unassigned |
2
1
4
0 |
| 2.7.4.21 | Carcinoma |
11337497 |
Inositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-beta in ovarian carcinoma cells. |
causal interaction
ongoing research
unassigned |
3
4
0 |
| 2.7.4.21 | Carcinoma |
11896621 |
Inositol hexakisphosphate kinase 2 sensitizes ovarian carcinoma cells to multiple cancer therapeutics. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
2
3
4
3 |
